About us
NSRI provides a comprehensive program of research and development of countermeasures for defense against WMD to defend our nation’s warfighters in the field. We possess the expertise, facilities, and resources to rapidly develop medical countermeasures (MCM) from exploration, design, and development to piloting, manufacturing and clinical trial execution. Our research has a demonstrated record of performance in: • Design & development of select agent vaccines • Novel preventative & prophylactic treatments for neurotoxins • Innovative approaches to vaccine and drug delivery • Research, development, test and evaluation of equipment providing therapeutic countermeasures for military and civilian use
- Website
-
https://nsri.nebraska.edu/researchcapabilities/medical-defence-against-wmds
External link for Active and Passive Detection of WMDs
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Omaha, NE
- Founded
- 2012